|
127 Companies |
|
123 Products |
|
123 Products |
|
59 Mechanisms of Action |
|
6 Trials |
|
3245 News |
|
| «12...4546474849505152535455...6566» |
- Enrollment open, Pneumococcal vaccines: Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Pneumonia and Pneumococcal Vaccine (clinicaltrials.gov) - Jul 11, 2013
P=N/A, N=60, Recruiting, Sponsor: Hospital General de Niños Pedro de Elizalde
Not yet recruiting --> Recruiting
- ceftriaxone / Generic mfg.
Enrollment closed: PLEASE: Persistent Lyme Empiric Antibiotic Study Europe (clinicaltrials.gov) - Jul 11, 2013
P4, N=270, Active, not recruiting, Sponsor: Radboud University
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial termination: GoldenCareTM for the Treatment of Bacterial Vaginosis (clinicaltrials.gov) - Jul 10, 2013
P1/2, N=8, Terminated, Sponsor: CDA Research Group, Inc.
Recruiting --> Active, not recruiting Recruiting --> Terminated; Company decided to stop study for reasons other than safety
- || Trial initiation date: Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals (clinicaltrials.gov) - Jul 10, 2013
P=N/A, N=757, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Terminated; Company decided to stop study for reasons other than safety Initiation date: Jan 2012 --> Nov 2012
- Enrollment change: GoldenCareTM for the Treatment of Bacterial Vaginosis (clinicaltrials.gov) - Jul 10, 2013
P1/2, N=8, Terminated, Sponsor: CDA Research Group, Inc.
Initiation date: Jan 2012 --> Nov 2012 N=60 --> 8
- || Cubicin (daptomycin) / Merck (MSD)
New P3 trial, Monotherapy: Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia (clinicaltrials.gov) - Jul 10, 2013
P3, N=206, Recruiting, Sponsor: Miquel Pujol
- ||||| New P2 trial: Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (clinicaltrials.gov) - Jul 10, 2013
P2, N=500, Recruiting, Sponsor: JN-International Medical Corporation
- ||||| Boostrix (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine) / GSK, Cervarix (recombinant human papillomavirus bivalent vaccine) / GSK, Japan Vaccine
Enrollment closed: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults (clinicaltrials.gov) - Jul 10, 2013
P3, N=1300, Active, not recruiting, Sponsor: GlaxoSmithKline
N=60 --> 8 Recruiting --> Active, not recruiting
- Trial completion: Efficacy Study of Thrice Weekly Directly Observed Treatment Short-Course Regimen in Tubercular Pleural Effusion (clinicaltrials.gov) - Jul 10, 2013
P=N/A, N=360, Completed, Sponsor: All India Institute of Medical Sciences, New Delhi
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||| Vabomere (meropenem/vaborbactam) / Melinta Therap
New P1 trial: Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects (clinicaltrials.gov) - Jul 10, 2013
P1, N=94, Completed, Sponsor: Rempex Pharmaceuticals
- Enrollment closed: Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants (clinicaltrials.gov) - Jul 10, 2013
P=N/A, N=1, Active, not recruiting, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting
- Trial completion: Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination (clinicaltrials.gov) - Jul 10, 2013
P1, N=82, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | biapenem / Generic mfg.
Trial completion: Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination (clinicaltrials.gov) - Jul 8, 2013
P1, N=30, Completed, Sponsor: Rempex Pharmaceuticals
Active, not recruiting --> Completed Recruiting --> Completed
- rifampicin / Generic mfg.
Trial initiation date: Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation (clinicaltrials.gov) - Jul 7, 2013
P2, N=30, Active, not recruiting, Sponsor: Universitas Padjadjaran
Recruiting --> Completed Initiation date: Mar 2013 --> Jun 2013
- Cubicin (daptomycin) / Merck (MSD)
Trial termination: STOP-NT: Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients (clinicaltrials.gov) - Jul 7, 2013
P4, N=100, Terminated, Sponsor: Henry Ford Health System
Initiation date: Mar 2013 --> Jun 2013 Recruiting --> Terminated; Independent biostatistician recommended early termination of the trial due to low probability of success.
- Cubicin (daptomycin) / Merck (MSD)
Enrollment change: STOP-NT: Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients (clinicaltrials.gov) - Jul 7, 2013
P4, N=100, Terminated, Sponsor: Henry Ford Health System
Recruiting --> Terminated; Independent biostatistician recommended early termination of the trial due to low probability of success. N=130 --> 100
- Kineret (anakinra) / SOBI
Trial completion: Anakinra as a Treatment for Hydradenitis Suppurativa (clinicaltrials.gov) - Jul 4, 2013
P2, N=6, Completed, Sponsor: University of California, San Francisco
N=130 --> 100 Recruiting --> Completed
- Trial completion: Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route (clinicaltrials.gov) - Jun 30, 2013
P1, N=24, Completed, Sponsor: University of Oxford
Recruiting --> Completed Active, not recruiting --> Completed
- New P1 trial: Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos (clinicaltrials.gov) - Jun 27, 2013
P1, N=60, Not yet recruiting, Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- Trial completion: Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule (clinicaltrials.gov) - Jun 26, 2013
P4, N=328, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open: Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis (clinicaltrials.gov) - Jun 26, 2013
P1, N=12, Recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | New P4 trial: 15-day Sequential Therapy for Helicobacter Pylori Infection in Korea (clinicaltrials.gov) - Jun 24, 2013
P4, N=287, Completed, Sponsor: Seoul National University Bundang Hospital
- Enrollment closed: Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult Volunteers (clinicaltrials.gov) - Jun 24, 2013
P1, N=60, Active, not recruiting, Sponsor: Infectious Disease Research Institute
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||||| Invanz (ertapenem) / Merck (MSD)
New P2 trial: A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia (clinicaltrials.gov) - Jun 23, 2013
P2, N=189, Completed, Sponsor: Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
- New P1/2 trial: Virgin Coconut Oil Oral Supplementation for Leprosy Patients (clinicaltrials.gov) - Jun 23, 2013
P1/2, N=26, Active, not recruiting, Sponsor: Philippine Dermatological Society
- Enrollment change: Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients (clinicaltrials.gov) - Jun 20, 2013
P=N/A, N=4807, Completed, Sponsor: University of Colorado, Denver
Recruiting --> Active, not recruiting N=13784 --> 4807
- Trial completion: Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients (clinicaltrials.gov) - Jun 20, 2013
P=N/A, N=4807, Completed, Sponsor: University of Colorado, Denver
N=13784 --> 4807 Enrolling by invitation --> Completed
- gemifloxacin mesylate / Generic mfg., azithromycin / Generic mfg., gentamicin sulfate / Generic mfg.
Trial completion, Combination therapy: Efficacy of Combination Therapies for Gonorrhea Treatment (clinicaltrials.gov) - Jun 19, 2013
P4, N=486, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Enrolling by invitation --> Completed Recruiting --> Completed
- ||| Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and hemophilus b conjugate) / Sanofi, Menactra (Meningococcal-groups A, C, Y and W-135 polysaccharide diphtheria toxoid conjugate vaccine) / Sanofi
Enrollment closed: Study of Menactra (clinicaltrials.gov) - Jun 16, 2013
P4, N=1394, Active, not recruiting, Sponsor: Sanofi Pasteur, a Sanofi Company
Recruiting --> Completed Recruiting --> Active, not recruiting
- PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer
Enrollment open: Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease (clinicaltrials.gov) - Jun 13, 2013
P=N/A, N=0, Recruiting, Sponsor: Pfizer
Recruiting --> Active, not recruiting Active, not recruiting --> Recruiting
- New P1 trial: Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults (clinicaltrials.gov) - Jun 13, 2013
P1, N=30, Recruiting, Sponsor: University of Oxford
- ||||| New P2 trial: BACTOvation™: Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis (clinicaltrials.gov) - Jun 12, 2013
P2, N=250, Recruiting, Sponsor: NovaBay Pharmaceuticals, Inc.
- Trial completion: Milk Ingredients and Resistance Against E-coli-induced GastroEnteritis (MIRAGE) (clinicaltrials.gov) - Jun 12, 2013
P=N/A, N=60, Completed, Sponsor: NIZO Food Research
Active, not recruiting --> Recruiting Active, not recruiting --> Completed
- ||| Trial completion: Healthcare Seeking Behaviour of Primary Caregivers for Acute Otitis Media (AOM) in Children Aged 6 Months to Less Than 30 Months in Panama (clinicaltrials.gov) - Jun 12, 2013
P=N/A, N=1330, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Recruiting --> Completed
- clindamycin phosphate / Generic mfg.
Trial initiation date: CLIN01: Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile (clinicaltrials.gov) - Jun 12, 2013
P1, N=32, Recruiting, Sponsor: Phillip Brian Smith
Recruiting --> Completed Initiation date: Jan 2013 --> Jun 2013
- |||| AMG 108 / AstraZeneca
Enrollment open: Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa (clinicaltrials.gov) - Jun 12, 2013
P2a, N=100, Recruiting, Sponsor: AstraZeneca
Initiation date: Jan 2013 --> Jun 2013 Not yet recruiting --> Recruiting
- clindamycin phosphate / Generic mfg.
Enrollment open: CLIN01: Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile (clinicaltrials.gov) - Jun 12, 2013
P1, N=32, Recruiting, Sponsor: Phillip Brian Smith
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Stelara (ustekinumab) / J&J
Enrollment closed: A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa (clinicaltrials.gov) - Jun 12, 2013
P2, N=20, Active, not recruiting, Sponsor: University Medical Centre Groningen
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- | azithromycin / Generic mfg.
Enrollment open: RESCUE-L: Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan) (clinicaltrials.gov) - Jun 11, 2013
P4, N=20, Enrolling by invitation, Sponsor: Pfizer
Recruiting --> Active, not recruiting Active, not recruiting --> Enrolling by invitation
- |||| clindamycin phosphate / Generic mfg.
Trial completion: PREMEVA: Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis (clinicaltrials.gov) - Jun 11, 2013
P4, N=3105, Completed, Sponsor: University Hospital, Lille
Active, not recruiting --> Enrolling by invitation Recruiting --> Completed
- Enrollment open: Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults (clinicaltrials.gov) - Jun 11, 2013
P1, N=30, Recruiting, Sponsor: University of Oxford
Recruiting --> Completed Not yet recruiting --> Recruiting
- chlorhexidine gluconate / Generic mfg.
Enrollment closed: Multicenter Blood Culture Quality Improvement (clinicaltrials.gov) - Jun 10, 2013
P=N/A, N=33000, Active, not recruiting, Sponsor: Vanderbilt University
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- || vancomycin / Generic mfg., linezolid oral / Generic mfg.
Clinical data, Enrollment change: Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia (clinicaltrials.gov) - Jun 9, 2013
P=N/A, N=5271, Completed, Sponsor: Pfizer
Recruiting --> Active, not recruiting N=9814 --> 5271
- |||| Cayston (aztreonam lysine) / Gilead
Trial completion: Aztreonam Lysine for Pseudomonas Infection Eradication Study (clinicaltrials.gov) - Jun 9, 2013
P2, N=105, Completed, Sponsor: Gilead Sciences
N=9814 --> 5271 Active, not recruiting --> Completed
- || levofloxacin / Generic mfg., cloxacillin / Generic mfg.
New P3 trial: Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus. (clinicaltrials.gov) - Jun 9, 2013
P3, N=154, Recruiting, Sponsor: Fundaci
- SQ-109 / Sequella
New P1 trial: Effects of SQ109 on QTc Interval in Healthy Subjects (clinicaltrials.gov) - Jun 9, 2013
P1, N=0, Withdrawn, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- meropenem / Generic mfg., colistin sulphate / Generic mfg.
Enrollment open: Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem (clinicaltrials.gov) - Jun 5, 2013
P4, N=360, Recruiting, Sponsor: Mical Paul
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||| Trial completion: Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals (clinicaltrials.gov) - Jun 5, 2013
P=N/A, N=757, Completed, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting Recruiting --> Completed
- Altabax (retapamulin) / GSK, Almirall
Trial completion: United States Pharmacovigilence Retapamulin-Prescribing (clinicaltrials.gov) - Jun 5, 2013
P=N/A, N=1, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed Active, not recruiting --> Completed
- Altabax (retapamulin) / GSK, Almirall
Trial completion: EU PV for Retapamulin-Prescribing (clinicaltrials.gov) - Jun 5, 2013
P=N/A, N=1, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Active, not recruiting --> Completed